Find Relief When Traditional Depression Treatments Haven't Worked
we help eligible patients access Spravato® (esketamine) treatment in a safe, supportive, and medically supervised environment. Working alongside your healthcare provider, we make the treatment process as smooth as possible while prioritizing your comfort and safety.
Get in touch with us!
Get in touch with us by phone, visit our pharmacy, or send us a message through the contact form
Free Home Delivery
Multi-Insurance Accepted
Competitive Cash Pricing
Expert Consultations
What Is Spravato®?
pravato® is the brand name for esketamine, a prescription nasal spray approved for adults with treatment-resistant depression (TRD) and, in certain situations, adults with major depressive disorder (MDD) experiencing acute suicidal thoughts or behaviors. Unlike traditional antidepressants that may take weeks to work, Spravato® acts on different brain pathways and is always used alongside an oral antidepressant as prescribed by your healthcare provider.
Who May Benefit From Spravato®?
Spravato® may be recommended for adults who:
Have treatment-resistant depression
Have tried multiple antidepressants without adequate improvement
Continue experiencing severe depressive symptoms
Need an alternative treatment option recommended by their psychiatrist
Qualify under FDA-approved prescribing guidelines
Are seeking supervised, evidence-based depression care
Why Choose Our Clinic for Spravato® Treatment?
Choosing the right provider is an important part of your mental health journey. Our team focuses on providing compassionate, patient-centered care throughout every stage of treatment.
Certified Treatment Facility
Experienced Healthcare Team
Comfortable Environment
Personalized Care Plans
Ongoing Patient Support
Convenient Scheduling
Our End-To-End Care Process
Initial Evaluation
Your healthcare provider reviews your medical history, current medications, and treatment goals to determine eligibility.
Treatment Planning
If Spravato® is appropriate, a personalized treatment schedule is created according to clinical guidelines.
In-Clinic Administration
Spravato® is self-administered as a nasal spray under direct medical supervision in our certified treatment center.
Observation Period
Patients remain under observation for approximately two hours after treatment to monitor blood pressure and overall wellbeing.
Ongoing Follow-Up
Regular assessments help your healthcare provider monitor progress and adjust your treatment plan as needed.
For Care Facilities
Conditions Spravato® May Help Treat
Spravato® is FDA-approved for specific conditions, including:
Treatment-Resistant Depression (TRD)
Major Depressive Disorder (MDD)
Frequently Asked Questions
Is Spravato® the same as ketamine?
No. Spravato® contains esketamine, a specific form of ketamine that has been FDA-approved for certain types of depression and is available only through certified treatment programs.
How long does each appointment take?
Most appointments last approximately two hours, including the required observation period after treatment.
Can I drive home afterward?
No. Patients should arrange transportation home after each treatment session because driving is not recommended until the following day after a restful night’s sleep.
Is Spravato® covered by insurance?
Many insurance plans may provide coverage for eligible patients. Our staff can help review benefits and assist with the authorization process whenever possible.
How many treatments will I need?
Treatment schedules vary based on your healthcare provider’s recommendations and your individual response to therapy.
Can’t find your answer? Our team is one call away.